Hard to believe how undervalued this company is right now.
Before Fda set us back to almost $2.68 Insmed was trading at $13.50 and now that all is well and dog study is completed hardly any recovery has taken place.
Just think about where Insmed would have been trading if all the FDA none sense never took place.
At least we got Mr. William H. Lewis as Chief Exec. Officer, Pres and Director out of this deal and that is worth $50 to me.
On a serious note - although the shares would indeed be priced at around 68 cents if the reverse split hadn't taken place, the market value of the Company is currently a lot more than it was when the share price was 68 cents.